Post Job Free
Sign in

Manager Project

Location:
Walpole, MA, 02081
Salary:
negotiable
Posted:
July 18, 2011

Contact this candidate

Resume:

Panduranga Adulla Reddy, Ph.D

** ******** ***** ****, *******, MA, 02081, USA

Phone: 617-***-**** (Cell); 508-***-**** (Home) email: s6bb29@r.postjobfree.com

** ***** ** ********** ***** record in drug discovery (Medicinal Chemistry as focus) in diverse therapeutic areas in pharmaceutical/biotech industry and 5 years as Assistant professor

High potential, accomplished Scientist/Leader/Manager. Lead discovery, Lead optimization, Project Leader to development stage. Instrumental in bringing two drugs from concept to Phase I/II clinical trials and several other programs to pre-clinical development stage. Lead Strategic Alliances activity including licensing and collaborations (search evaluation of contracts/agreements and take part in negotiations with potential partners). Developed external partnering strategy and executed the strategy in chemistry and ADME Tox services. Attracted, retained top talent and built loyal, high performing teams. Managed group(s) at multiple sites. Identify the scope, writing the drafts of patents, and associated with patent attorneys from filing through prosecution. Effectively communicated the vision and strategy to diverse (multi-disciplinary) teams/groups at geographically different locations. Result oriented in fast-paced, changing, and challenging environment. Put in place clear strategy (operational plans, explicitly stated goals and objectives) & Budget planning.

Ph.D. (Organic Chemistry)

Post doctoral research in synthesis and biophysical studies on peptides at CUNY, New York, followed by Structure Based Design and synthesis of peptide and peptidomimetic CD4 protein (CDR3 domain) inhibitors for autoimmune diseases at Thomas Jefferson University.

Patents [37, issued/published (29), filed (8)] and papers [38, published (33) & in press/in preparation (5)]

Professional Experience: Industrial

Consulting (2011): TargAnox USA), ToxiKon(USA), Hetero drugs Ltd(India) on their discovery programs

Merck Research Labs: Senior Principal Scientist (Section Leader): Nov.2009-Dec., 2010

Leading the multiple projects as project leader/manager [lead discovery and lead optimization stages (Oncology)]

One program (Kinase inhibitor) nominated for preclinical evaluation. Managed a chemistry team (~10) comprised of Ph.Ds. and M.S.

Schering Plough Research Institute: Senior Principal Scientist (Section Leader): Nov.2002-Nov.2009 [Acquired by Merck)

Leading the multiple projects [lead discovery and lead optimization stages (Oncology, infectious, and inflammation disease areas)]. Two programs (Oncology) in clinical trials (Phase I/II) and multiple programs (inflammation, infectious & CNS) at various levels. Managed a chemistry team (~10) comprised of Ph.Ds. and M.S.

Serono Research Institute: Principal Scientist & Group Leader: 1995- Oct.2002. [Acquired by Merck KGA]

Built chemistry group (20+ chemists) and closely working/interacting with interdisciplinary teams in US & across Atlantic. Focus on the therapeutic areas of woman health and inflammation. One program entered in Phase I (GnRH antagonists, endometriosis and endometrial cancer) and three programs [woman health (FSH LHRH, GnRH agonists/antagonists) and inflammation/COPD (EP2/EP4 agonists] evaluated in preclinical studies. Managed a chemistry team (10-14) comprised of Ph.Ds. and M.S.

Professional Experience: Academic: Teaching and Research

Thomas Jefferson University: 1993-1994

Post doctoral Visiting Scientist: Molecular modeling and design of peptides and peptidomimetic inhibitors of CD4 protein for autoimmune diseases.

City University of New York: 1992-1993

Post doctoral Visiting Scientist: Biophysical studies on structure of Peptide ligands & GPCR Protein transmembrane fragments

Osmania University: 1985-1991

Assistant Professor: In addition to teaching to M.S. (Organic Chemistry), guided students for their Ph.D. degree

Leadership Style:

Empower people to do their jobs responsibly and ensure that they take ownership, accountability and motivated to achieve the goals and objectives.

Delegate the work to people to work with team spirit, so that they assume ownership. Encourages teamwork and believes that team success is success of all. Recognition and pride associated with success is important.

Liaison/Project management: Working with multi disciplinary groups/Selecting CRO’s, Collaborative Research Partners [external (academic and industrial research partners)].

Experience interpreting, coordinating in vitro and in vivo biological data and coordination with diverse groups.

Coordinate with the DMPK & in vivo biology groups to optimize the timelines for effective results

Project Management Training:

Serono Corporate Management (2000)

Mass Biotech Council (2004)

Management Training:

Change Leadership Development Academy for corporate excellence 2000

Negotiate to Win American Management Association 1999

Patents & Involvement with patents/intellectual property:

37 patents (issued, published (29) & filed (8)].Worked with a team of patent attorneys (Legal, I.P.).

[Identify the scope, writing drafts, associated all the way to the filing and prosecution].

Papers/presentations published:

33 published and 5 in press/manuscript preparation

Computational tools/methods

Modest experience with computational chemistry (Tripos, Schrodinger, Accelrys, ACD, Pymol etc) and chemo informatics tools. Well versed with Microsoft windows tools including project management.

Examples of a Creative Solution to a Scientific OR Business Problem

A, When a backup molecule for an oncology project, Research leadership committee has asked a different chemical series with better profile and stipulated time, took the lead role in designing, identifying and accomplishing in delivering the preclinical candidate with desired profile.

B, When there was management set time lines on results and too few people, set the priorities, motivate people with opportunity and reward. Outsourced the needs of medicinal chemistry and coordinated all tasks to get the results in desired time frame. Nominated for CEO award for “Scientific Leadership” at Serono

Factors Important to Ensure Job Satisfaction

Scientific challenge. Team environment and Successful achievement of goals.

Unique, Applicable Characteristics that Candidate Brings to Position

Leadership through honesty/transparency/harmony and lead by example

All aspects drug discovery: Target identification through development [lead generation, lead optimization (medicinal chemistry, DMPK, in vivo Biology & Safety-- all the way to development).]

PATENTS, PRESENTATIONS AND PAPERS:

Patents:

1. Reddy, Panduranga Adulla; Siddiqui, M. Arshad; Wong, Tzu Tshin.; Heterocyclic amide compounds as protein kinase inhibitors and theirpreparation and use for the treatment of cancer.; PCT Int. Appl. (2011), WO 201******* A2 20110303.

2, Cheng, Cliff C.; Zeng, Hongbo; Shipps, Gerald W., Jr.; Deng, Yongqi; Meng, Zhaoyang; Zhao, Lianyun; Nan, Yang; Sun, Binyuan; Liu, Duan; Reddy, Panduranga A.; Siddiqui, M. Arshad. Fused tricyclic compounds as mTOR inhibitors and their preparation and use for the treatment of cancer ; PCT Int. Appl. (2011), WO 201******* A1 20110106

3, Deng, Yongqi; Sun, Binyuan; Zeng, Hongbo; Richards, Matthew; Shipps, Gerald W., Jr.; Cheng, Cliff C.; Zhao, Yinyan; McRiner, Andrew; Meng, Zhaoyang; Nan, Yang; Patel, Mehul F.; Wrona, Iwona E.; Reddy, Panduranga Adulla; Eklov, Brian M.; Tang, Shuyi; Liu, Duan; Mandal, Amit K.; Zhao, Lianyun; Siddiqui, M. Arshad. Pyrazolo [1, 5-a] pyrimidine derivatives as m-TOR inhibitors. PCT Int. Appl. (2010), 726pp. CODEN: PIXXD2 WO 201******* A1 20101014

4, Ciavarri, Jeffrey P.; Reddy, Panduranga A.; Siddiqui, M. Arshad; Zhao, Lianyun. Preparation of imidazopyrazines as therapeutic protein and checkpoint kinase inhibitors. PCT Int. Appl. (2010), 100pp. CODEN: PIXXD2 WO 201******* A2 20100805

5, Mansoor, Umar Faruk; Reddy, Panduranga Adulla; Siddiqui, M. Arshad. Preparation of urea derivatives as antibacterial agents for treatment of diseases mediated by LpxC. PCT Int. Appl. (2010), 75pp. CODEN: PIXXD2 WO 201******* A1 20100211

6, Reddy, Panduranga Adulla P.; Mansoor, Umar Faruk; Siddiqui, M. Arshad. Preparation of heterocyclic compounds as LpxC inhibitors for use as antibacterial agents. PCT Int. Appl. (2009), 84pp. CODEN: PIXXD2 WO 200-***-**** A1 20091230

7, Ciavarri, Jeffrey P.; Reddy, Panduranga Adulla P.; Siddiqui, M. Arshad; Zhao, Lianyun. Preparation of imidazopyrazines as therapeutic protein and checkpoint kinase inhibitors. U.S. Pat. Appl. Pub. (2009), 63pp. Cont.-in-part of U.S. Ser. No. 758,243. CODEN: USXXCO US 200-***-**** A1 20090709

8, Reddy, Panduranga Adulla P.; Wong, Tzu T.; Zhao, Lianyun; Tang, Shuyi; Labroli, Marc A.; Guzi, Timothy J.; Siddiqui, M. Arshad. Preparation of thiazole derivatives as protein kinase inhibitors. PCT Int. Appl. (2009), 141pp. CODEN: PIXXD2 WO 200-***-**** A1 20090507

9, Labroli, Marc A.; Poker, Cory Seth; Wong, Tzu T.; Reddy, Panduranga Adulla P.; Guzi, Timothy J.; Siddiqui, M. Arshad. Preparation of thiazole diamides as protein kinase inhibitors. PCT Int. Appl. (2009), 105pp. CODEN: PIXXD2 WO 200-***-**** A1 20090507

10, Reddy, Panduranga Adulla P.; Zhao, Lianyun; Tadikonda, Praveen K.; Wong, Tzu Tshin; Tang, Shuyi; Torres, Luis E.; Cauble, David F., Jr.; Guzi, Timothy J.; Siddiqui, M. Arshad. Heterocyclic amide compounds as protein kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. PCT Int. Appl. (2009), 245pp. CODEN: PIXXD2 WO 200-***-**** A2 20090129

11, Reddy, Panduranga Adulla P.; Siddiqui, Arshad M.; Tadikonda, Praveen K.; Mansoor, Umar Faruk; Shipps, Gerald W., Jr.; Belanger, David B.; Zhao, Lianyun. Preparation of imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines, and imidazo[1,2-d]triazines as JNK and ERK kinase inhibitors. PCT Int. Appl. (2008), 362pp. CODEN: PIXXD2 WO 200-***-**** A2 20080710

12, Belanger, David B.; Siddiqui, M. Arshad; Curran, Patrick J.; Hamann, Blake; Zhao, Lianyun; Reddy, Panduranga Adulla P.; Tadikonda, Praveen K.; Shipps, Gerald W., Jr.; Mansoor, Umar Faruk. Preparation of pyridines and pyrimidines as JNK and ERK kinase inhibitors. PCT Int. Appl. (2008), 243pp. CODEN: PIXXD2 WO 200-***-**** A2 20080710

13, Belanger, David B.; Siddiqui, M. Arshad; Guzi, Timothy J.; Curran, Patrick J.; Tadikonda, Praveen K.; Hamann, Blake; Reddy, Panduranga Adulla P.; Zhao, Lianyun. Preparation of imidazopyrazines as protein kinase inhibitors. PCT Int. Appl. (2008), 138 pp. CODEN: PIXXD2 WO 200-***-**** A2 20080515

14, Shipps, Gerald W., Jr.; Cheng, Cliff C.; Huang, Xiaohua; Fischmann, Thierry O.; Duca, Jose S.; Richards, Matthew; Zeng, Hongbo; Sun, Binyuan; Reddy, Panduranga A.; Wong, Tzu T.; Tadikonda, Praveen K.; Siddiqui, M. Arshad; Labroli, Marc M.; Poker, Cory; Guzi, Timothy J. Anilinopiperazine derivatives and methods of use thereof and their preparation. PCT Int. Appl. (2008), 330 pp. CODEN: PIXXD2 WO 200-***-**** A1 20080508

15, Shipps, Gerald W., Jr.; Cheng, Cliff C.; Huang, Xiaohua; Fischmann, Thierry O.; Duca, Jose S.; Richards, Matthew; Zeng, Hongbo; Sun, Binyuan; Reddy, Panduranga A.; Zhao, Lianyun; Tang, Shuyi; Wong, Tzu T.; Tadikonda, Praveen K.; Torres, Luis E.; Siddiqui, M. Arshad; Dwyer, Michael P.; Keertikar, Kartik M.; Guzi, Timothy J. 2-Aminothiazole-4-carboxylic amides as protein kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. PCT Int. Appl. (2008), 274pp. CODEN: PIXXD2 WO 200-***-**** A1 20080508

16, Mansoor, Umar Faruk; Reddy, Panduranga Adulla P.; Siddiqui, M. Arshad. Preparation of methylhydantoin derivatives for use as antimicrobial agents. PCT Int. Appl. (2008), 97 pp. CODEN: PIXXD2 WO 200-***-**** A1 20080306

17, Zhao, Lianyun; Reddy, Panduranga Adulla P.; Shih, Neng-Yang; Paruch, Kamil; Guzi, Timothy J.; Siddiqui, M. Arshad. Imidazopyrazines as protein kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of kinase-mediated diseases. PCT Int. Appl. (2007), 145pp. CODEN: PIXXD2 WO 200-***-**** A1 20071221

18, Siddiqui, M. Arshad; Mansoor, Umar Faruk; Reddy, Panduranga Adulla P.; Madison, Vincent S. Preparation of tartaric acid functional compounds for the treatment of disorders mediated by MMPs, aggrecanase, ADMP, LpxC, ADAMs, TACE and TNF- U.S. Pat. Appl. Publ. (2007), 556pp. Cont.-in-part of U.S. Ser. No. 291,595. CODEN: USXXCO US 200-***-**** A1 20070719

19, Siddiqui, M. Arshad; Mansoor, Umar Faruk; Reddy, Panduranga A.; Madison, Vincent S. 2,3-Dihydroxybutane-1,4-diamide compounds for the treatment of inflammatory disorders and microbial diseases and their preparation. PCT Int. Appl. (2007), 119pp. CODEN: PIXXD2 WO 200-***-**** A1 20070607

20, Zhao, Lianyun; Curran, Patrick J.; Belanger, David B.; Hamann, Blake; Reddy, Panduranga A.; Paruch, Kamil; Guzi, Timothy. J.; Dwyer, Michael P.; Siddiqui, M. Arshad; Tadikonda, Praveen K. Preparation of imidazopyrazines as protein kinase inhibitors. PCT Int. Appl. (2007), 276 pp. CODEN: PIXXD2 WO 200-***-**** A2 20070524

21, Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Parry, David A.; Zhao, Lianyun; Curran, Patrick J.; Belanger, David B.; Hamann, Blake; Reddy, Panduranga Adulla P.; Siddiqui, M. Arshad; Tadikonda, Praveen K. Imidazopyrazine compounds and their methods for inhibiting protein kinases, preparation, pharmaceutical compositions and use in the treatment of protein kinase-associated diseases. U.S. Pat. Appl. Publ. (2007), 346pp. CODEN: USXXCO US 200-***-**** A1 20070510

22, Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Siddiqui, M. Arshad; Reddy, Panduranga Adulla P.; Belanger, David B.; Hamann, Blake; Curran, Patrick J. Preparation of novel pyrazolopyrimidines as cyclin dependent kinase inhibitors. U.S. Pat. Appl. Publ. (2007), 60 pp., Cont.-in-part of U.S. Ser. No. 244,776. CODEN: USXXCO US 200-***-**** A1 20070329

23, Siddiqui, M. Arshad; Manor, Muar Faro; Reddy, Panduranga A.; Madison, Vincent S. Preparation of tartaric acid functional compounds for the treatment of inflammatory disorders mediated by MMPs, aggrecanase, ADMP, LpxC, ADAMs, TACE and TNF- U.S. Pat. Appl. Publ. (2006), 523 pp., Cont.-in-part of U.S. Ser. No. 142,601. CODEN: USXXCO US 200-***-**** A1 20060810

24, Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Zhao, Lianyun; Curran, Patrick J.; Belanger, David B.; Hamann, Blake; Reddy, Panduranga A.; Siddiqui, M. Arshad. Preparation of novel imidazopyrazines as cyclin dependent kinase inhibitors. U.S. Pat. Appl. Publ. (2006), 161 pp., Cont.-in-part of U.S. Ser. No. 47,524. CODEN: USXXCO US 200-***-**** A1 20060518

25, Araldi, Gian Luca; Karra, Srinivasa; Reddy, Adulla P.; Liao, Yihua; Zhao, Zhong. Preparation of thiophenes and furans as prostaglandin, in particular prostaglandin EP2, agonists. PCT Int. Appl. (2004), 109 pp. CODEN: PIXXD2 WO 200-***-**** A2 20040212

26, Araldi, Gian Luca; Reddy, Adulla P.; Zhao, Zhong; Mckenna, Sean D.; Bao, Bagna. Preparation of -lactams as prostaglandin EP4 agonists and uses thereof. PCT Int. Appl. (2003), 137 pp. CODEN: PIXXD2 WO 200-***-**** A2 20031218

27, Araldi, Gian Luca; Liao, Yihua; Reddy, Adulla P.; Zhao, Zhong. Preparation of pyrazolidinones as ligands of the prostaglandin EP2 and/or EP4 receptors. PCT Int. Appl. (2003), 106 pp. CODEN: PIXXD2 WO 200-***-**** A1 20030501

28, Shroff, Hitesh; Reddy, Adulla P.; El Tayar, Nabil; Brugger, Nadia; Jorand-Lebrun, Catherine. Preparation of pyrazole compounds for treatment of infertility. PCT Int. Appl. (2001), 90 pp. CODEN: PIXXD2 WO 200******* A2 20011122

29, El Tayer, Nabil; Reddy, Adulla; Buckler, David; Magar, Sharad. Preparation of carbazoles, isoquinolines, indoles, and related compounds as follicle stimulating hormone mimetics for the treatment of infertility. PCT Int. Appl. (2000), 62 pp. CODEN: PIXXD2 WO 200******* A2 20000217

Patents filed: Nine Patents filed

List of papers/presentations published:

1, U. Faruk Mansoor, Dilrukshi Vitharana, Panduranga Adulla Reddy, Dayna L. Daubaras, Paul McNicholas, Peter Orth, Todd Black, M. Arshad Siddiqui., Design and synthesis of potent Gram-negative specific LpxC inhibitors Bioorganic & Medicinal Chemistry Letters., 21,(4),1155-1161(2011)

2, Zhaoyang Meng, Bheemashankar A. Kulkarni, Angela D. Kerekes, Johannes Voigt, Amit K. Mandal, Sara J. Esposite, David B. Belanger, Panduranga Adulla Reddy, Andrea D. Basso, Kimberly Gray, Seema Tevar, Jennifer Jones, Elizabeth Smith, Ronald Doll M. Arshad Siddiqui. Biosteric approach to the discovery of imidazo[1,2-a] pyrazines as potent Aurora Kinase inhibitors., Bioorganic & Medicinal Chemistry Letters 21, (1), 592-598 (2011).

3, Zhaoyang Meng, Bheemashankar A. Kulkarni, Angela D. Kerekes, Johannes Voigt, Amit K. Mandal, Sara J. Esposite, David B. Belanger, Panduranga Adulla Reddy, Andrea D. Basso, Kimberly Gray, Seema Tevar, Jennifer Jones, Elizabeth Smith, M. Arshad Siddiqui, Ronald Doll, From Isothiazole to Thiophene and Thiazole: A BioisostericApproach to the Discovery of Potent Imidazo[1,2-a]pyrazines as Aurora Kinase Inhibitors., Abstracts of Papers, 240th ACS National Meeting, Boston, MA, United States, August 22-26, 2010 (2010),

4, Siddiqui, M. Arshad; Reddy, Panduranga A.. Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors. Journal of Medicinal Chemistry (2010), 53(8), 3005-3012. CODEN: JMCMAR ISSN:0022-2623. CAN 152:372532 AN 2010:176474 CAPLUS

5, Xiao, Yufang; Araldi, Gian Luca; Zhao, Zhong; Reddy, Adulla; Karra, Srinivasa; Brugger, Nadia; Fischer, David; Palmer, Elizabeth; Bao, Bagna; Mckenna, Sean D. Synthesis and evaluation of a -lactam as a highly selective EP2 and EP4 receptor agonist. Bioorganic & Medicinal Chemistry Letters (2008), 18(2), 821-824. CODEN: BMCLE8 ISSN:0960-894X. CAN 148:379408 AN 2008:85194 CAPLUS

6, Zhao, Zhong; Araldi, Gian Luca; Xiao, Yufang; Reddy, Adulla P.; Liao, Yihua; Karra, Srinivasa; Brugger, Nadia; Fischer, David; Palmer, Elizabeth. Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists. Bioorganic & Medicinal Chemistry Letters (2007), 17(23), 6572-6575. CODEN: BMCLE8 ISSN: 0960-894X. CAN 148:121623 AN 2007:1279259 CAPLUS

7, Jorand-Lebrun, Catherine; Brondyk, Bill; Lin, Jing; Magar, Sharad; Murray, Robert; Reddy, Adulla; Shroff, Hitesh; Wands, Greg; Weiser, Weishui; Xu, Qihong; McKenna, Sean; Brugger, Nadia. Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists. Bioorganic & Medicinal Chemistry Letters (2007), 17(7), 2080-2085. CODEN: BMCLE8 ISSN: 0960-894X. CAN 146:501311 AN 2007:267455 CAPLUS

8, Zhao, Zhong; Bao, Bagna; Brugger, Nadia; Fischer, David; Giachetti, Claudio; Golzio, Lucia; Karra, Srinivasa; Marinelli, Paolo; McKenna, Sean; Palmer, Elizabeth; Reddy, Adulla; Xiao, Yufang; Araldi, Gian Luca. Discovery of potent prostaglandin EP2 and EP4 receptors agonists that inhibit bronchomuscle constriction in guinea pigs. Abstracts of Papers, 228th ACS National Meeting, Philadelphia, PA, United States, August 22-26, 2004 (2004), MEDI-056. CODEN: 69FTZ8 AN 2004:657920 CAPLUS

9, Gautam Agnihotri, Margaret Porter Scott, Moulay Hicham Alaoui-Ismaili, Faruk Mansoor, Denise Murphy, Adulla P. R. Reddy, Gerald Shipps, Arshad Siddiqui, Praveen Tadikonda, Charles Whitehurst, and Huw Nash. Identification of Potent Inhibitors of c-Jun N-terminal Kinase – 1 using Ultra High-Throughput Affinity-Based Screening

Presentation at the 12th Symposium on Second Messengers and Phospho-proteins (SMP-2004), Montreal, QC. (Aug 3 - Aug 7, 2004).

10, Zhao, Zhong; Bao, Bagna; Brugger, Nadia; Fischer, David; Giachetti, Claudio; Golzio, Lucia; Karra, Srinivasa; Marinelli, Paolo; McKenna, Sean; Palmer, Elizabeth; Reddy, Adulla; Xiao, Yufang; Araldi, Gian Luca. Discovery of potent prostaglandin EP2 and EP4 receptors agonists that inhibit bronchomuscle constriction in guinea pigs. Abstracts of Papers, ACS National Medicinal Chemistry symposium, Madison, Wisconsin, United States, June 27-1st July, 2004 (2004),

11, Zhang Zhao, Adulla P.R.Reddy, Yihua Liao, Srinivas Karra, Araldi Gian Luca*

Preparation of pyrazole compounds for treatment of infertility

XVIIIth International Symposium on Medicinal chemistry, Copenhagen, Sweden, August , 2004

12, El Tayar, Nabil; Reddy, Adulla; Liao, Yihua; Magar, Sharad; Murray, Robert; Kozack, Richard; Weiser, Weishui; Nabioullin, Roustem; Rosenthal, Judy; Buckler, David; Cheng, Shirley; Liu, Jane; McKenna, Sean; Jiang, Xuliang; Evans, David; Tepper, Mark; Goutopoulos, Andreas. Small Molecule FSH-mimetics. Abstracts of Papers, 224th ACS National Meeting, Boston, MA, United States, August 18-22, 2002 (2002), MEDI-355. CODEN: 69CZPZ AN 2002:618206 CAPLUS

13, Goutopoulos, Andreas; Reddy, Adulla; Liao, Yihua; Magar, Sharad; Murray, Robert; Weiser, Weishui; Nabioullin, Roustem; Rosenthal, Judy; Buckler, David; Cheng, Shirley; Liu, Jane; McKenna, Sean; Jiang, Xiuliang; Evans, David; Tepper, Mark; El Tayar, Nabil. Proline and pipecolic acid-based agonists of the follicle-stimulating hormone receptor. Abstracts of Papers, 226th ACS National Meeting, New York, NY, United States, September 7-11, 2003 (2003), MEDI-365. CODEN: 69EKY9 AN 2003:634973 CAPLUS

14, Zhao, Zhong; Bao, Bagna; Brugger, Nadia; Fischer, David; Giachetti, Claudio; Golzio, Lucia; Karra, Srinivasa; Marinelli, Paolo; McKenna, Sean; Palmer, Elizabeth; Reddy, Adulla; Xiao, Yufang; Araldi, Gian Luca. Discovery of potent prostaglandin EP2 and EP4 receptors agonists that inhibit bronchomuscle constriction in guinea pigs. Abstracts of Papers, 228th ACS National Meeting, Philadelphia, PA, United States, August 22-26, 2004 (2004), MEDI-056. CODEN: 69FTZ8 AN 2004:657920 CAPLUS

15, Friedman, Thea M.; Reddy, Adulla P.; Wassell, Richard; Jameson, Bradford A.; Korngold, Robert. Identification of a human CD4-CDR3-like surface involved in CD4+ T cell function. Journal of Biological Chemistry (1996), 271(37), 226**-*****. CODEN: JBCHA3 ISSN: 0021-9258. CAN 125:219068 AN 1996:572224 CAPLUS

16, Reddy, A. P.; Tallon, M. A.; Becker, J. M.; Naider, F. Biophysical studies on fragments of the -factor receptor protein. Biopolymers (1994), 34(5), 679-89. CODEN: BIPMAA ISSN:0006-3525. CAN 121:151521 AN 1994:551521 CAPLUS

17, Reddy, K. Hemender; Reddy, A. Panduranga; Veeranagaiah, V. Synthesis of alkyl/aryl substituted pyrazolo[1,5-a]pyrimidines. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1993), 32B (5), 586-9. CODEN: IJSBDB ISSN: 0376-4699. CAN 121:9352 AN 1994:409352 CAPLUS

18, Rao, V Sudhakar; Rao, S Sreedhar Prasad; Reddy, A. Panduranga; Veeranagaiah, V. Studies on the formation of 2-methyl-imidazo [4, 5-g] benzothiazoles from 6,7-diamino-2-methylbenzothiazole. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1993), 32B (3), 322-7. CODEN: IJSBDB ISSN: 0376-4699. CAN 119:28053 AN 1993:428053 CAPLUS

19, Rao, M. Hanumantha; Reddy, A. Pandu Ranga; Veeranagaiah, V. Synthesis of 1H-1,5-benzodiazepin-2(3H)-ones from 5(4H)-isoxazolone, a heterocyclic bifunctional C-3 synthon. Synthesis (1992), (5), 446-8. CODEN: SYNTBF ISSN: 0039-7881. CAN 117:69839 AN 1992:469839 CAPLUS

20, Reddy, K. Hemender; Reddy, A. Panduranga; Veeranagaiah, V. Versatile synthesis of 6-alkyl(aryl)-1H-pyrazolo[3,4-d]pyrimidin-4[5H]-ones. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1992), 31B (3), 163-6. CODEN: IJSBDB ISSN:0376-4699. CAN 116:174107 AN 1992:174107 CAPLUS

21, Rao, M. Hanmantha; Reddy, A. Pandu Ranga; Veeranagaiah, V. A convenient approach to the synthesis of quinoxalines from isoxazolones and 1, 2-diaminobenzenes. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1992), 31B(2), 88-91. CODEN: IJSBDB ISSN: 0376-4699. CAN 116:128865 AN 1992:128865 CAPLUS

22, Rao, M. Hanmantha; Reddy, A. Pandu Ranga; Veeranagaiah, V. A new synthetic approach towards the synthesis of 2-(3-aryl-2H-1,4-benzothiazin-2-yl)-3-aryl-2H-1,4-benzothiazines. Synthetic Communications (1991), 21(17), 1715-20. CODEN: SYNCAV ISSN: 0039-7911. CAN 115:232157 AN 1991:632157 CAPLUS

23, Reddy, A. Panduranga; Reddy, C. P. R. Kasi. An efficient method for the synthesis of N-(p-aminobenzoyl) amino acids. Organic Preparations and Procedures International (1990), 22(1), 117-19. CODEN: OPPIAK ISSN: 0030-4948. CAN 113:24482 AN 1990:424482 CAPLUS

24, Rao, S. Krishan; Reddy, A. Pandu Ranga; Veeranagaiah, V. Synthesis of imidazo-, pyrazino- and diazepinoquinoxalines from quinoxaline-5,6-diamine and ketones. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1989), 28B (11), 918-22. CODEN: IJSBDB ISSN: 0376-4699. CAN 112:118768 AN 1990:118768 CAPLUS

25, Reddy, A. Panduranga; Veeranagaiah, V. Studies on the stability of 2,2,4-trialkyl-2,3-dihydro-1H-[1,4]diazepino[2,3-f]quinolines. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1989), 28B (3), 272-3. CODEN: IJSBDB ISSN: 0376-4699. CAN 111:134110 AN 1989:534110 CAPLUS

26, Rao, S. Kishan; Reddy, A. Pandu Ranga; Veeranagaiah, V. Synthesis of 2-substituted 1H-imidazo [4, 5-f] quinoxalines. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1988), 27B (10), 960-1. CODEN: IJSBDB ISSN: 0376-4699. CAN 111:97184 AN 1989:497184 CAPLUS

27, Reddy, B. Saida; Reddy, A. Panduranga; Veeranagaiah, V. One-pot synthesis of 3-aryl-2,3-dihydro-2-thioxobenzofuro[3,2-d]pyrimidin-4(1H)-ones. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1988), 27B(12), 1131-3. CODEN: IJSBDB ISSN: 0376-4699. CAN 111:77951 AN 1989:477951 CAPLUS

28, Reddy, A. Ram; Reddy, A. Pandu Ranga. Exciplex formation in 2-propanol solutions of imidazo [4, 5-f] quinolines. Journal of Photochemistry (1987), 38 255-61. CODEN: JPCMAE ISSN: 0047-2670. CAN 108:55348 AN 1988:55348 CAPLUS

29, Reddy, A. Pandu Ranga; Veeranagaiah, V. Condensation of quinoline-5, 6-diamine with ketones. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1986), 25B(5), 527-9. CODEN: IJSBDB ISSN: 0376-4699. CAN 106:67273 AN 1987:67273 CAPLUS

30, Reddy, A Pandu Ranga; Veeranagaiah, V. Studies on the formation of imidazo [4,5-f]quinolines from quinoline-5,6-diamine and aromatic aldehydes. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1985), 24B (4), 372-6. CODEN: IJSBDB ISSN: 0376-4699. CAN 104:109533 AN 1986:109533 CAPLUS

31, Reddy, A. Pandu Ranga; Veeranagaiah, V.; Ratnam, C. V. Synthesis and autoxidation of 1,3-dialkyl-2-arylbenzimidazolines. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1985), 24B (4), 367-71. CODEN: IJSBDB ISSN: 0376-4699. CAN 104:109532 AN 1986:109532 CAPLUS

32, Reddy, A. Pandu Ranga; Veeranagaiah, V. A facile synthesis of 2-substituted imidazo [4, 5-f] quinolines. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1984), 23B (7), 673-4. CODEN: IJSBDB ISSN: 0376-4699. CAN 101:211049 AN 1984:611049 CAPLUS

33, Reddy, A. Pandu Ranga; Veeranagaiah, V. Condensation of quinoline-5,6-diamine with benzaldehyde. Current Science (1982), 51(1), 39. CODEN: CUSCAM ISSN: 0011-3891. CAN 98:34546 AN 1983:34546 CAPLUS

*** Five more are in preparation



Contact this candidate